These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30674975)

  • 21. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
    Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
    BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
    Yang W; Lee KW; Srivastava RM; Kuo F; Krishna C; Chowell D; Makarov V; Hoen D; Dalin MG; Wexler L; Ghossein R; Katabi N; Nadeem Z; Cohen MA; Tian SK; Robine N; Arora K; Geiger H; Agius P; Bouvier N; Huberman K; Vanness K; Havel JJ; Sims JS; Samstein RM; Mandal R; Tepe J; Ganly I; Ho AL; Riaz N; Wong RJ; Shukla N; Chan TA; Morris LGT
    Nat Med; 2019 May; 25(5):767-775. PubMed ID: 31011208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.
    Sundara YT; Kostine M; Cleven AH; Bovée JV; Schilham MW; Cleton-Jansen AM
    Cancer Immunol Immunother; 2017 Jan; 66(1):119-128. PubMed ID: 27853827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.
    Rao PH; Zhao S; Zhao YJ; Yu A; Rainusso N; Trucco M; Allen-Rhoades W; Satterfield L; Fuja D; Borra VJ; Man TK; Donehower LA; Yustein JT
    Genes Chromosomes Cancer; 2015 Dec; 54(12):796-808. PubMed ID: 26355645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Massive NGS data analysis reveals hundreds of potential novel gene fusions in human cell lines.
    Gioiosa S; Bolis M; Flati T; Massini A; Garattini E; Chillemi G; Fratelli M; Castrignanò T
    Gigascience; 2018 Oct; 7(10):. PubMed ID: 29860514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational Analysis of Gene Fusions Predicts Novel MHC Class I-Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer.
    Kalina JL; Neilson DS; Lin YY; Hamilton PT; Comber AP; Loy EMH; Sahinalp SC; Collins CC; Hach F; Lum JJ
    Clin Cancer Res; 2017 Dec; 23(24):7596-7607. PubMed ID: 28954787
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion transcript detection using spatial transcriptomics.
    Friedrich S; Sonnhammer ELL
    BMC Med Genomics; 2020 Aug; 13(1):110. PubMed ID: 32753032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma.
    Weibo P; Zhaoming Y
    Med Hypotheses; 2012 May; 78(5):616-8. PubMed ID: 22330890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancer.
    Krzyzanowski PM; Sircoulomb F; Yousif F; Normand J; La Rose J; E Francis K; Suarez F; Beck T; McPherson JD; Stein LD; Rottapel RK
    Sci Rep; 2019 Mar; 9(1):3590. PubMed ID: 30837567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
    Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
    Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer.
    Teles Alves I; Hartjes T; McClellan E; Hiltemann S; Böttcher R; Dits N; Temanni MR; Janssen B; van Workum W; van der Spek P; Stubbs A; de Klein A; Eussen B; Trapman J; Jenster G
    Oncogene; 2015 Jan; 34(5):568-77. PubMed ID: 24488012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTRK fusions in osteosarcoma are rare and non-functional events.
    Ameline B; Saba KH; Kovac M; Magnusson L; Witt O; Bielack S; Nathrath M; Nord KH; Baumhoer D
    J Pathol Clin Res; 2020 Apr; 6(2):107-112. PubMed ID: 32022484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel fusion genes and chimeric transcripts in ependymal tumors.
    Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
    Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent read-through fusion transcripts in breast cancer.
    Varley KE; Gertz J; Roberts BS; Davis NS; Bowling KM; Kirby MK; Nesmith AS; Oliver PG; Grizzle WE; Forero A; Buchsbaum DJ; LoBuglio AF; Myers RM
    Breast Cancer Res Treat; 2014 Jul; 146(2):287-97. PubMed ID: 24929677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.
    McPherson A; Hormozdiari F; Zayed A; Giuliany R; Ha G; Sun MG; Griffith M; Heravi Moussavi A; Senz J; Melnyk N; Pacheco M; Marra MA; Hirst M; Nielsen TO; Sahinalp SC; Huntsman D; Shah SP
    PLoS Comput Biol; 2011 May; 7(5):e1001138. PubMed ID: 21625565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NeoFuse: predicting fusion neoantigens from RNA sequencing data.
    Fotakis G; Rieder D; Haider M; Trajanoski Z; Finotello F
    Bioinformatics; 2020 Apr; 36(7):2260-2261. PubMed ID: 31755900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.